Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for ipo industry professionals · Friday, March 29, 2024 · 699,660,260 Articles · 3+ Million Readers

Aortic Valve Market to Witness a CAGR of 10.3% during 2018–2023: P&S Intelligence

Aortic Valve Market by Product (Valve Type [Tissue/Biological, Mechanical], Suture Type [Sutured, Sutureless]), by Procedure (Minimally Invasive Surgery [Transfemoral, Transapical], Open Surgery [Tissue/Biological, Mechanical]), by End User (Hospitals, Ambulatory Surgery Centers), by Geography (Germany, France, U.K., Italy, Spain, U.S., Canada, Japan, China, Taiwan, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, aortic valve market is expected to reach $9,859.8 million by 2023. Owing to rising prevalence of valvular heart diseases (VHDs), increasing preference for minimally invasive surgeries (MISs), initiatives for creating awareness about valve replacement, and favorable reimbursement scenario related to aortic valves.

Request to get the sample pages of the report: https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample

Based on product, the market is bifurcated in terms of valve type and suture type. On the basis of valve type, the aortic valve market has been categorized into tissue/biological and mechanical valves. Tissue/biological aortic valves held 88.1% share in the market in 2017. This can be mainly attributed to advancements in technology and rising adoption of tissue/biological valves, globally.

Based on suture type, the aortic valve market for sutureless valves is projected to witness significant growth during the forecast period, with 22.9% CAGR in terms of value. This can be mainly ascribed to the advantages of these valves over sutured valves, such as reduction in the duration of cross-clamp and cardiopulmonary bypass (CPB) procedures. It is further predicted that over 30 thousand units of sutureless aortic valves would be sold by 2023, as compared to over 8 thousand valves sold in 2017.

Browse report overview with 319 tables and 78 figures spread through 254 pages and detailed TOC on "Aortic Valve Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at: https://www.psmarketresearch.com/market-analysis/aortic-valve-market

Aortic valves can either be replaced through open surgeries or MISs. The MISs for aortic valve implantation held larger share in the aortic valve market in 2017, with a revenue contribution of $3,519.8 million. This can be attributed to the fact that MISs, unlike open surgeries, involve a smaller number of incisions to reduce trauma.

In comparison to global market growth, the European market is expected to observe the fastest growth during the forecast period, with 11.6% CAGR, owing to the increasing prevalence of cardiovascular diseases (CVDs), growing acceptance for technologically advanced products, and improving healthcare infrastructure in the region. The European aortic valve market is driven by factors, such as significant prevalence of aortic stenosis in the European countries, availability of various treatment options including transcatheter aortic valve replacement (TAVR), and rising initiatives for creating awareness about valve replacement surgeries in the region.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aortic-valve-market

Companies are attaining a number of approvals for their products, in order to enter into the aortic valve market. For instance, in June 2018, LivaNova PLC received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW), for its Perceval sutureless aortic heart valve, which is used for the treatment of aortic valve diseases. Before that, in March 2018, LivaNova PLC received Conformité Européene (CE) approval for its Bicarbon aortic valves for use with a low-dose anticoagulant therapy. This expanded indication of the company’s Bicarbon family of mechanical valves was based on the evidence and results collected from the LOWERING-IT trial, where patients saw 60% reduction in the risk of bleeding.

Some of the other key players in the aortic valve industry are Boston Scientific Corporation, Edwards Lifesciences Corporation, CryoLife Inc., Medtronic plc, Abbott Laboratories, Venus Medtech (Hangzhou) Inc., and LifeNet Health.

More Reports by P&S Intelligence

Breast Biopsy Devices Market

During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region. According to National Institute of Cancer Prevention and Research, breast cancer is the most common cancer in women in India and accounts for about a quarter of all cancers in women in Indian cities, and the average age for breast cancer in India is almost a decade lower than that in the West.

https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market

Wearable Fitness Trackers Market

The wearable fitness trackers industry is expected to witness fastest growth in Asia-Pacific (APAC), owing to the presence of local players providing low cost fitness tracker devices, rising adoption of fitness trackers due to increasing prevalence of chronic diseases, and surge in the number of internet users and e-shoppers.

https://www.psmarketresearch.com/market-analysis/wearable-fitness-trackers-market

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

P&S-Intelligence..jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release